It has been further observed that tumor cells might evade immune system surveillance through the interaction between PD-L1 and PD-L2 with their receptor PD-1, which is expressed on CD4 and CD8 T-cells, Tregs, B-cells, and natural killer (NK) cells. This evidence concerns the gene CD4 and neoplasm.